Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1424 NOK | -1.66% | -5.32% | -48.78% |
Business Summary
Number of employees: 25
Sales per Business
NOK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Innovative Drugs
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -49.74% |
Sales per region
NOK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Norway
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -49.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Martin Olin
CEO | Chief Executive Officer | 55 | 21-09-07 |
Rune Skeie
DFI | Director of Finance/CFO | 51 | 18-03-04 |
Nigel McCracken
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
James Barnes
COO | Chief Operating Officer | - | 19-02-28 |
Cristina Oliva
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-24 |
Debbie Molyneux
HRO | Human Resources Officer | - | 18-12-31 |
Gayle Mills
PRN | Corporate Officer/Principal | 69 | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sally Bennett
BRD | Director/Board Member | 52 | 20-12-08 |
Sveinung Hole
BRD | Director/Board Member | 57 | 10-08-31 |
Chairman | 63 | 22-01-05 | |
Director/Board Member | 61 | 19-03-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,688,689,214 | 2,472,694,294 ( 91.97 %) | 0 | 91.97 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.78% | 51.23M | |
-1.19% | 103B | |
+8.85% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.19% | 16.94B | |
+6.72% | 14.07B | |
+39.11% | 12.35B |
- Stock Market
- Equities
- BGBIO Stock
- Company BerGenBio ASA